Last year saw record consolidation and corporate action in the investment trust sector. If the past seven months are anything to go by, 2025 will be a year of note as well. At the beginning of the year, 20 trusts were undergoing managed wind-downs, and since January, a further six have proposed or had wind-downs approved, according to Deutsche Numis.
Wind-downs usually happen because an asset class, strategy or individual trust is out of favour. At the same time, they can present a new opportunity if they offer a timetable and a catalyst for realising value from a portfolio that is persistently trading at a deep discount to net asset value (NAV).
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Investment trusts winding down
Abrdn European Logistics Income (LSE: ASLI) entered a managed wind-down last year following a failed sales process for the entire portfolio. It sold three assets in the first quarter of the year and returned an initial £16.5 million to investors (5.3% of its NAV). Following additional sales, 16 of its 27 assets have now been liquidated and further capital returns are planned in August and September. The estimated NAV is now 57.9p, reckon analysts at Deutsche Numis, putting the shares on a discount of 17%.
JPMorgan Global Core Real Assets (LSE: JARA) failed a continuation vote in September and is now returning assets to investors. The first cash from sales, totalling £33 million or 17% of NAV, was paid in February. Further sales are in the pipeline, and the trust expects to redeem 80% of assets by the end of 2026. The end-June NAV of 89.1p implies the shares are trading at a discount of 11%.
Following a strategic review, Riverstone Energy (LSE: RSE) has proposed a managed wind-down, with investors set to vote on this on 22 August. Management has laid out a plan to distribute two-thirds of the capital by 31 March 2026, with the remaining illiquid assets sold by the end of 2027. The trust’s reported discount has recently narrowed to 22%, based on the latest NAV of 1,136p.
Investors need to be aware that the manager is getting a termination fee of 7.5% of realisation proceeds, but even allowing for that, the discount is still in double-digits.
Investment trusts to watch
Syncona (LSE: SYNC), the once high-flying backer of early-stage biotech companies, announced in June that it will wind down its portfolio. The trust has said it will aim to continue supporting key companies in its portfolio and open a private vehicle for those investors interested in rolling their investment over. This puts a question mark over the liquidation timetable, but with a discount of about 40% there could be a lot of value there for patient investors.
Life Science Reit (LSE: LABS), which announced a strategic review in March, recently said it has received significant interest from buyers for parts of the portfolio. Management is also continuing to explore a managed wind-down. The portfolio includes assets at Oxford Technology Park and Cambourne Park Science & Tech Campus – both located in two high-growth, tech-focused areas of the country – and King’s Cross in London. The Reit has struggled since listing (recent leasing has been slower than expected, with occupancy now at 85%) and has suspended its dividend. But at a 32% discount to NAV, it is worth watching closely.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
‘My NS&I one-year British Savings Bond is maturing – what should I do with my savings?Thousands of savers will see their fixed-rate savings accounts mature next month. We consider whether you should stick with NS&I or move to a competitor
-
London Stock Exchange gets go-ahead to run Pisces private stock marketThe Pisces market will allow investors to buy and sell shares in private companies. But how will it work, when will it launch, and who is allowed to use it?
-
Investors rediscover the virtue of value investing over growthGrowth investing, betting on rapidly expanding companies, has proved successful since 2008. But now the other main investment style seems to be coming back into fashion.
-
What we can learn from Britain’s "Dashing Dozen" stocksStocks that consistently outperform the market are clearly doing something right. What can we learn from the UK's top performers and which ones are still buys?
-
Europe’s forgotten equities offer value, growth and strong cash flowsOpinion Jonathon Regis, co-portfolio manager, Developed Markets UCITS Strategy, Lansdowne Partners, highlights forgotten equities he'd put his money in
-
The flaw in Terry Smith’s strategy at FundsmithOpinion Fundsmith has invested in some excellent companies, but it has struggled to decide when to sell, says Max King
-
How to invest in the travel industry's boom as tourists get back on the roadThe travel industry is in rude health despite uncertainty about the global economy, Trump’s policies and geopolitical concerns. Investors should buy in now
-
Earnings estimates are a rigged game – especially in the USThe number of US stocks beating earnings estimates tells us only that guidance has deliberately been set too low
-
Profit from the potential in funds focusing on private assetsOpinion Charlotte Cuthbertson and Tom Treanor of the Migo Opportunities Trust highlight three funds where they'd put their money
-
How to approach active ETFsActive ETFs have several advantages over other forms of open-ended investment vehicles, says David Prosser
